New Pre-Clinical Research Further Validates Potential for Focused Ultrasound in Alzheimer's

A pre-clinical study published this week in Science Translational Medicine suggests that focused ultrasound may hold a key to providing a non-invasive, non-pharmaceutical approach to treating Alzheimer’s disease.

stm cover mar11

Researchers from the Queensland Brain Institute in Australia demonstrated that combining the injection of microbubbles and applying ultrasound across the brain using a system from Philips Research reduced the number and volume of amyloid plaques in mice genetically altered to model Alzheimer’s disease. In addition, they found that treated mice had improved memory over untreated ones.

Within just a few hours of publication, the research generated interest around the world, with many leading news sources reporting on the study. “Our research was very exploratory and we really didn’t expect to see such a massive effect,” study author Jürgen Götz told Reuters. “I’m really excited by this.”

This important work conducted by Götz and Gerhard Leinenga, neuroscience researchers who are experts in Alzheimer’s disease, corroborates studies done at Sunnybrook Research Institute under the leadership of focused ultrasound pioneer Kullervo Hynynen. Hynynen and his colleagues were the first to publish data suggesting the benefit of focused ultrasound and microbubbles to open the blood-brain barrier (BBB) and reduce the plaque burden in a different Alzheimer’s model. Similarly, Foundation-funded preclinical research at Columbia University by Elisa Konofagou, PhD, safely opened the BBB to treat neurogenerative conditions—including Alzheimer’s.

Foundation Chairman Neal F. Kassell, MD, stated, “These two studies in separate laboratories using different models are the essential predicate for a clinical trial. Combining these data with a successful safety and efficacy study for opening the blood-brain barrier, which is beginning soon at Sunnybrook, could get us there.”

alzheimers illustrationAlthough the research is still preliminary, having two validated approaches that use focused ultrasound to eliminate plaques is very promising. “This research makes a wonderful connection between the focused ultrasound community and the neuroscience community that studies Alzheimer’s disease at the most basic cellular level,” said the Foundation’s Chief Scientific Officer Jessica Foley, PhD. “The attention that it is receiving will shed light on the important and immediate advances that are being made to treat a range of brain disorders.”

The Foundation is organizing a steering committee to support additional Alzheimer’s research from preclinical stages to clinical trials.

Read the News Coverage from Science Magazine, The Wall Street Journal, The Guardian, International Business Times, and the Australian.

Read more about Dr. Hynynen’s team’s progress on Alzheimer’s and other diseases.

Image Sources:

(1) STM's online cover image: Bubbles, Beams, and Microglial Activation. Transient opening of the blood-brain barrier results in activation of microglial cells (yellow), which then start engulfing amyloid plaques (gray) in a mouse model of Alzheimer's disease. Transient opening of the tight junctions of endothelial cells (red) that comprise the blood-brain barrier was induced by injected microbubbles and an ultrasound beam. From G. Leinenga, J. Götz, Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model. Sci. Transl. Med. 7, 278ra33 (2015). Reprinted with permission from AAAS. CONCEPT NICK VALMAS, THE UNIVERSITY OF QUEENSLAND/ILLUSTRATION BY V. ALTOUNIAN/SCIENCE TRANSLATIONAL MEDICINE

(2) Sunnybrook Research Institute



Share this page

0 #19 Evelyn Buckle 2017-10-16 04:39
Yes please, bring on the Clinical Trials ASAP.

Look at the advances in Cancer treatments and Heart Disease, everything excepting Dementia.

We must explore the causes and treatment of ALL sorts of Dementia aggressively.
0 #18 Michele 2017-04-01 02:33
The FDA approved focused ultrasound for uterine fibroids back in 2004 but as of 2017 we have had zero clinical trials for Alzheimers?!
+1 #17 John Johnsen 2017-03-27 19:27
My wife was a surcigal nurse for 30 years. She has Alzheimer's in mid-stages. Why can't trials be started asap. These people have no future but getting worse. What is there to wait for. You would get 1000's of volunteers. These prelimary tests take too long.
0 #16 FUS Foundation 2017-01-13 12:44
Hello Willis,

Unfortunately, at this time there are no open clinical trials for Alzheimer's in the US. You can find more information on Alzheimer's here (, and this page will remain updated with any further information.
0 #15 Willis Kroger 2017-01-11 19:56
where are they going to do the study in the JSA and who do I contact to get my wife on the study we live near Omaha and Lincoln Nebraska. Please respond. Thank You very much Willis
0 #14 Elizabeth 2016-12-23 17:15
My sisterinlaw Debra asks me all the time when the clinical trials are coming she's 60
0 #13 Sarah Degenaars 2016-09-06 03:41
My mom is 72 and has Alzheimer's. It has been beyond painful for our family. As ridiculous as it may may sound, I have been praying for a miracle. I believe the clinical trials in humans could be her and our miracle. Please notify me of requirements to qualify and which hospitals are being considered when the information becomes available. Thank u!
0 #12 FUS Foundation 2016-08-25 16:40
Hello all - Thank you for you interest in focused ultrasound and how it may apply to treating Alzheimer's disease. Unfortunately, there have been no clinical advances to date with this therapy, as the shift from pre-clinical studies to studies in humans is a slow process. We will be sure to report on any news that does arise. We suggest that you subscribe to our monthly newsletter list ( and stay tuned to our Alzheimer's page (
+1 #11 Donna reeves 2016-08-16 08:01
My Dad is showing early signs of Alzheimer's. I can't watch another loved one go thru this. We lost both my grandmothers, mother in law, father in law and my husbands uncle to this horrid disease.
My dad is in too good shape to loose him to this. He is 75 and very healthy, he also walks and works out. He is the smartest person I know. This will totally devastate my family, I can't loose him too.
Clinical trials may begin in 2017... My family is well aware of the stages of Alzheimer's and believe he would be a perfect candidate for this. Not only can my dad tell an improvement but my family is very close and can also be able to tell a difference.
This is amazing news! Is it in time to save my dad?
0 #10 John 2016-08-12 04:52
What does a person need to do to become a candiate
for a trial? Has the FDA fast tracked this study and if so what university is doing this study in the USA?
Does Australia have this study on a fast track approval
study? THank you in advance for any information.
Add comment